Northwestern Mutual Wealth Management CO Alaunos Therapeutics, Inc. Transaction History

Northwestern Mutual Wealth Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$0.62 - $1.17 $380 - $718	-614 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$1.09 - $1.89 $669 - $1,160	614 New	614 $1,000
Q2 2018 Aug 10, 2018	SELL	$3.02 - $4.94 $3,020 - $4,940	-1,000 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$3.46 - $5.14 $3,460 - $5,140	1,000 New	1,000 $4,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.